Epithelial antimicrobial peptides: Guardian of the oral cavity

International Journal of Peptides

Volumn 2014, Issue , 2014, Pages

  Hans, Mayank ^a   Madaan Hans, Veenu ^b  

^a ESIC MEDICAL COLLEGE AND HOSPITAL   (India)

^b SGT UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; BETA DEFENSIN; CALGRANULIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; PROBIOTIC AGENT;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; CELL PROLIFERATION; DISEASE COURSE; DRUG STRUCTURE; EPITHELIUM; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MINIMUM INHIBITORY CONCENTRATION; MOUTH CAVITY; NONHUMAN; REVIEW; TOOTH PLAQUE; WOUND HEALING;

EID: 84912142886     PISSN: 16879767     EISSN: 16879775     Source Type: Journal    
DOI: 10.1155/2014/370297     Document Type: Review

References (134)

1. Pöllänen M. T.; Salonen J. I.; Uitto V.-J.; Structure and function of the tooth-epithelial interface in health and disease. Periodontology 2000 2003 31 1 12 31 10.1034/j.1600-0757.2003.03102.x 2-s2.0-0037263876
2. Schroeder H. E.; Listgarten M. A.; The gingival tissues: The architecture of periodontal protection. Periodontology 2000 1997 14 1 91 120 2-s2.0-0031061830
3. Tonetti M. S.; Molecular factors associated with compartmentalization of gingival immune responses and transepithelial neutrophil migration. Journal of Periodontal Research 1997 32 1 104 109 10.1111/j.1600-0765.1997.tb01389.x 2-s2.0-0030632109
4. Dale B. A.; Periodontal epithelium: A newly recognized role in health and disease. Periodontology 2000 2002 30 1 70 78 10.1034/j.1600-0757.2002.03007.x 2-s2.0-0347540289
5. Diamond G.; Beckloff N.; Ryan L. K.; Host defense peptides in the oral cavity and the lung: similarities and differences. Journal of Dental Research 2008 87 10 915 927 10.1177/154405910808701011 2-s2.0-58149252357
6. Ganz T.; Selsted M. E.; Szklarek D.; Harwig S. S.; Daher K.; Bainton D. F.; Lehrer R. I.; Defensins. Natural peptide antibiotics of human neutrophils. The Journal of Clinical Investigation 1985 76 4 1427 1435 10.1172/JCI112120 2-s2.0-0022402545
7. Oppenheim F. G.; Xu T.; McMillian F. M.; Levitz S. M.; Diamond R. D.; Offner G. D.; Troxler R. F.; Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. Journal of Biological Chemistry 1988 263 16 7472 7477 2-s2.0-0023888810
8. Weinberg A.; Krisanaprakornkit S.; Dale B. A.; Epithelial antimicrobial peptides: review and significance for oral applications. Critical Reviews in Oral Biology and Medicine 1998 9 4 399 414 10.1177/10454411980090040201 2-s2.0-0032313341
9. Boman H. G.; Hoffmann J.; Natori S.; Janeway C.; Cecropins: antibacterial peptides from insects and pigs. Phylogenetic Perspectives in Immunity: The Insect-Host Defense 1994 Austin, Tex, USA Landes Biomed 24 37
10. Zasloff M.; Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proceedings of the National Academy of Sciences of the United States of America 1987 84 15 5449 5453 10.1073/pnas.84.15.5449 2-s2.0-2042513493
11. Romeo D.; Skerlavaj B.; Bolognesi M.; Gennaro R.; Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. Journal of Biological Chemistry 1988 263 20 9573 9575 2-s2.0-0023746603
12. Schonwetter B. S.; Stolzenberg E. D.; Zasloff M. A.; Epithelial antibiotics induced at sites of inflammation. Science 1995 267 5204 1645 1648 10.1126/science.7886453 2-s2.0-0028902757
13. Dale B. A.; Krisanaprakornkit S.; Defensin antimicrobial peptides in the oral cavity. Journal of Oral Pathology and Medicine 2001 30 6 321 327 10.1034/j.1600-0714.2001.300601.x 2-s2.0-0034929327
14. Mathews M.; Jia H. P.; Guthmiller J. M.; Losh G.; Graham S.; Johnson G. K.; Tack B. F.; McCray P. B. Jr.; Production of β -defensin antimicrobial peptides by the oral mucosa and salivary glands. Infection and Immunity 1999 67 6 2740 2745 2-s2.0-0344483901
15. Diamond G.; Zasloff M.; Eck H.; Brasseur M.; Lee Maloy W.; Bevins C. L.; Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proceedings of the National Academy of Sciences of the United States of America 1991 88 9 3952 3956 10.1073/pnas.88.9.3952 2-s2.0-0025811874
16. Kagan B. L.; Ganz T.; Lehrer R. I.; Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology 1994 87 1-3 131 149 10.1016/0300-483X(94)90158-9 2-s2.0-0028331319
17. Abiko Y.; Saitoh M.; Nishimura M.; Yamazaki M.; Sawamura D.; Kaku T.; Role of β -defensins in oral epithelial health and disease. Medical Molecular Morphology 2007 40 4 179 184 10.1007/s00795-007-0381-8 2-s2.0-37249084758
18. Dale B. A.; Kimball J. R.; Krisanaprakornkit S.; Roberts F.; Robinovitch M.; O'Neal R.; Valore E. V.; Ganz T.; Anderson G. M.; Weinberg A.; Localized antimicrobial peptide expression in human gingiva. Journal of Periodontal Research 2001 36 5 285 294 10.1034/j.1600-0765.2001.360503.x 2-s2.0-0035486840
19. Lu Q.; Samaranayake L. P.; Darveau R. P.; Jin L.; Expression of human β -defensin-3 in gingival epithelia. Journal of Periodontal Research 2005 40 6 474 481 10.1111/j.1600-0765.2005.00827.x 2-s2.0-27944437531
20. Krisanaprakornkit S.; Weinberg A.; Perez C. N.; Dale B. A.; Expression of the peptide antibiotic human β -defensin 1 in cultured gingival epithelial cells and gingival tissue. Infection and Immunity 1998 66 9 4222 4228 2-s2.0-0031662487
21. Premratanachai P.; Joly S.; Johnson G. K.; McCray P. B. Jr.; Jia H. P.; Guthmiller J. M.; Expression and regulation of novel human β -defensins in gingival keratinocytes. Oral Microbiology and Immunology 2004 19 2 111 117 10.1111/j.0902-0055.2002.00127.x 2-s2.0-1442338497
22. Bensch K. W.; Raida M.; Mägert H. J.; Schulz-Knappe P.; Forssmann W. G.; hBD-1: a novel β -defensin from human plasma. FEBS Letters 1995 368 2 331 335 10.1016/0014-5793(95)00687-5 2-s2.0-0028981702
23. Liu L.; Zhao C.; Heng H. H. Q.; Ganz T.; The human β -defensin-1 and α-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics 1997 43 3 316 320 10.1006/geno.1997.4801 2-s2.0-0031213832
24. Ganz T.; Defensins: antimicrobial peptides of innate immunity. Nature Reviews Immunology 2003 3 9 710 720 10.1038/nri1180 2-s2.0-0141799911
25. Harder J.; Bartels J.; Christophers E.; Schröder J. M.; A peptide antibiotic from human skin. Nature 1997 387 6636 861 10.1038/43088 2-s2.0-0030820726
26. Harder J.; Siebert R.; Zhang Y.; Matthiesen P.; Christophers E.; Schlegelberger B.; Schröder J.-M.; Mapping of the gene encoding human β -defensin-2 (DEFB2) to chromosome region 8p22-p23.1. Genomics 1997 46 3 472 475 10.1006/geno.1997.5074 2-s2.0-0031573999
27. Jia H. P.; Schutte B. C.; Schudy A.; Discovery of new human β -defensins using a genomics-based approach. Gene 2001 263 1-2 211 218 10.1016/S0378-1119(00)00569-2 2-s2.0-0035941493
28. Harder J.; Bartels J.; Christophers E.; Schröder J.-M.; Isolation and characterization of human betadefensin-3, a novel human inducible peptide antibiotic. The Journal of Biological Chemistry 2001 276 8 5707 5713 10.1074/jbc.M008557200 2-s2.0-0035937107
29. Offenbacher S.; Barros S. P.; Paquette D. W.; Gingival transcriptome patterns during induction and resolution of experimental gingivitis in humans. Journal of Periodontology 2009 80 12 1963 1982 10.1902/jop.2009.080645 2-s2.0-72749111423
30. Lu Q.; Jin L.; Darveau R. P.; Samaranayake L. P.; Expression of human β -defensins-1 and -2 peptides in unresolved chronic periodontitis. Journal of Periodontal Research 2004 39 4 221 227 10.1111/j.1600-0765.2004.00727.x 2-s2.0-3242751259
31. Diamond G.; Beckloff N.; Weinberg A.; Kisich K. O.; The roles of antimicrobial peptides in innate host defense. Current Pharmaceutical Design 2009 15 21 2377 2392 10.2174/138161209788682325 2-s2.0-69249096200
32. Conti H. R.; Shen F.; Nayyar N.; Stocum E.; Sun J. N.; Lindemann M. J.; Ho A. W.; Hai J. H.; Yu J. J.; Jung J. W.; Filler S. G.; Masso-Welch P.; Edgerton M.; Gaffen S. L.; Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. Journal of Experimental Medicine 2009 206 2 299 311 10.1084/jem.20081463 2-s2.0-63049138176
33. Selsted M. E.; Tang Y.-Q.; Morris W. L.; McGuire P. A.; Novotny M. J.; Smith W.; Henschen A. H.; Cullor J. S.; Purification, primary structures, and antibacterial activities of β -defensins, a new family of antimicrobial peptides from bovine neutrophils. The Journal of Biological Chemistry 1993 268 9 6641 6648 2-s2.0-0027514011
34. Gardner M. S.; Rowland M. D.; Siu A. Y.; Bundy J. L.; Wagener D. K.; Stephenson J. L. Jr.; Comprehensive defensin assay for Saliva. Analytical Chemistry 2009 81 2 557 566 10.1021/ac801609r 2-s2.0-60549100316
35. Tao R.; Jurevic R. J.; Coulton K. K.; Tsutsui M. T.; Roberts M. C.; Kimball J. R.; Wells N.; Berndt J.; Dale B. A.; Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrobial Agents and Chemotherapy 2005 49 9 3883 3888 10.1128/AAC.49.9.3883-3888.2005 2-s2.0-24144432828
36. Joly S.; Maze C.; McCray P. B. Jr.; Guthmiller J. M.; Human β-defensins 2 and demonstrate strain selective activity against oral microorganisms. Journal of Clinical Microbiology 2004 42 3 1024 1029 10.1128/JCM.42.3.1024-1029.2004 2-s2.0-1542513868
37. Ji S.; Hyun J.; Park E.; Lee B.-L.; Kim K.-K.; Choi Y.; Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. Journal of Periodontal Research 2007 42 5 410 419 10.1111/j.1600-0765.2006.00962.x 2-s2.0-34548230420
38. Feng Z.; Jiang B.; Chandra J.; Ghannoum M.; Nelson S.; Weinberg A.; Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. Journal of Dental Research 2005 84 5 445 450 10.1177/154405910508400509 2-s2.0-21744462099
39. Feng Z.; Dubyak G. R.; Lederman M. M.; Weinberg A.; Cutting edge: human β defensin 3-a novel antagonist of the HIV-1 coreceptor CXCR4. The Journal of Immunology 2006 177 2 782 786 10.4049/jimmunol.177.2.782 2-s2.0-33745851881
40. Ji S.; Shin J. E.; Kim Y. C.; Choi Y.; Intracellular degradation of Fusobacterium nucleatum in human gingival epithelial cells. Molecules and Cells 2010 30 6 519 526 10.1007/s10059-010-0142-8 2-s2.0-79957733056
41. Ouhara K.; Komatsuzawa H.; Yamada S.; Shiba H.; Fujiwara T.; Ohara M.; Sayama K.; Hashimoto K.; Kurihara H.; Sugai M.; Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, β -defensins and LL37, produced by human epithelial cells. Journal of Antimicrobial Chemotherapy 2005 55 6 888 896 10.1093/jac/dki103 2-s2.0-21244433198
42. Shelburne C. E.; Coulter W. A.; Olguin D.; Lantz M. S.; Lopatin D. E.; Induction of β -defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrobial Agents and Chemotherapy 2005 49 1 183 187 10.1128/AAC.49.1.183-187.2005 2-s2.0-11244356891
43. Shin J. E.; Choi Y.; Treponema denticola suppresses expression of human β -defensin-2 in gingival epithelial cells through inhibition of TNF α production and TLR2 activation. Molecules and cells 2010 29 4 407 412 10.1007/s10059-010-0048-5 2-s2.0-77956039738
44. Agawa Y.; Lee S.; Ono S.; Aoyagi H.; Ohno M.; Taniguchi T.; Anzai K.; Kirino Y.; Interaction with phospholipid bilayers, ion channel formation, and antimicrobial activity of basic amphipathic α -helical model peptides of various chain lengths. Journal of Biological Chemistry 1991 266 30 20218 20222 2-s2.0-0025724956
45. Cole A. M.; Ganz T.; Liese A. M.; Burdick M. D.; Liu L.; Strieter R. M.; Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity. Journal of Immunology 2001 167 2 623 627 10.4049/jimmunol.167.2.623 2-s2.0-0035879198
46. Yang D.; Biragyn A.; Kwak L. W.; Oppenheim J. J.; Mammalian defensins in immunity: more than just microbicidal. Trends in Immunology 2002 23 6 291 296 10.1016/S1471-4906(02)02246-9 2-s2.0-0036606951
47. Yang D.; Chertov O.; Bykovskaia S. N.; β -defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999 286 5439 525 528 10.1126/science.286.5439.525 2-s2.0-0033569408
48. Niyonsaba F.; Ogawa H.; Nagaoka I.; Human β -defensin-2 functions as a chemotactic agent for tumour necrosis factor-α-treated human neutrophils. Immunology 2004 111 3 273 281 10.1111/j.0019-2805.2004.01816.x 2-s2.0-1642318503
49. 2 production from mast cells. European Journal of Immunology 2001 31 4 1066 1075
50. Niyonsaba F.; Ushio H.; Nakano N.; Ng W.; Sayama K.; Hashimoto K.; Nagaoka I.; Okumura K.; Ogawa H.; Antimicrobial peptides human β -defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. Journal of Investigative Dermatology 2007 127 3 594 604 10.1038/sj.jid.5700599 2-s2.0-33847040438
51. Kohlgraf K. G.; Pingel L. C.; Dietrich D. E.; Brogden K. A.; Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiology 2010 5 1 99 113 10.2217/fmb.09.104 2-s2.0-75849147159
52. Semple F.; Webb S.; Li H.-N.; Patel H. B.; Perretti M.; Jackson I. J.; Gray M.; Davidson D. J.; Dorin J. R.; Human β -defensin 3 has immunosuppressive activity in vitro and in vivo. European Journal of Immunology 2010 40 4 1073 1078 10.1002/eji.200940041 2-s2.0-77951046523
53. Sorensen O. E.; Cowland J. B.; Theilgaard-Mönch K.; Liu L.; Ganz T.; Borregaard N.; Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. The Journal of Immunology 2003 170 11 5583 5589 10.4049/jimmunol.170.11.5583 2-s2.0-0038189571
54. Yang D.; Biragyn A.; Hoover D. M.; Lubkowski J.; Oppenheim J. J.; Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annual Review of Immunology 2004 22 181 215 10.1146/annurev.immunol.22.012703.104603 2-s2.0-2542480000
55. Ramanathan B.; Davis E. G.; Ross C. R.; Blecha F.; Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes and Infection 2002 4 3 361 372 10.1016/S1286-4579(02)01549-6 2-s2.0-0036218636
56. Zaiou M.; Gallo R. L.; Cathelicidins, essential gene-encoded mammalian antibiotics. Journal of Molecular Medicine 2002 80 9 549 561 10.1007/s00109-002-0350-6 2-s2.0-0036379140
57. Gennaro R.; Zanetti M.; Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 2000 55 31 49
58. Gudmundsson G. H.; Agerberth B.; Odeberg J.; Bergman T.; Olsson B.; Salcedo R.; The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. European Journal of Biochemistry 1996 238 2 325 332 10.1111/j.1432-1033.1996.0325z.x 2-s2.0-0029893253
59. Larrick J. W.; Hirata M.; Balint R. F.; Lee J.; Zhong J.; Wright S. C.; Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infection and Immunity 1995 63 4 1291 1297 2-s2.0-0028949278
60. Nilsson M. F.; Sandstedt B.; Sørensen O.; Weber G.; Borregaard N.; Stahle-Backdahl M.; The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infection and Immunity 1999 67 5 2561 2566 2-s2.0-0032903987
61. Murakami M.; Ohtake T.; Dorschner R. A.; Gallo R. L.; Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. Journal of Dental Research 2002 81 12 845 850 10.1177/154405910208101210 2-s2.0-0036891933
62. Turkoglu O.; Emingil G.; Kutukçuler N.; Atilla G.; Gingival crevicular fluid levels of cathelicidin ll-37 and interleukin-18 in patients with chronic periodontitis. Journal of Periodontology 2009 80 6 969 976 10.1902/jop.2009.080532 2-s2.0-67649964706
63. Hosokawa I.; Hosokawa Y.; Komatsuzawa H.; Goncalves R. B.; Karimbux N.; Napimoga M. H.; Seki M.; Ouhara K.; Sugai M.; Taubman M. A.; Kawai T.; Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue. Clinical and Experimental Immunology 2006 146 2 218 225 10.1111/j.1365-2249.2006.03200.x 2-s2.0-33750077258
64. Zanetti M.; Gennaro R.; Scocchi M.; Skerlavaj B.; Structure and biology of cathelicidins. Advances in Experimental Medicine and Biology 2000 479 203 218 2-s2.0-0034478144
65. Sorensen O. E.; Cowland J. B.; Theilgaard-Mönch K.; Liu L.; Ganz T.; Borregaard N.; Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. Journal of Immunology 2003 170 11 5583 5589 10.4049/jimmunol.170.11.5583 2-s2.0-0038189571
66. Weber G.; Heilborn J. D.; Jimenez C. I. C.; Hammarsjö A.; Törmä H.; Ståhle M.; Vitamin D induces the antimicrobial protein hCAP18 in human skin. Journal of Investigative Dermatology 2005 124 5 1080 1082 10.1111/j.0022-202X.2005.23687.x 2-s2.0-18244394526
67. Türkoglu O.; Emingil G.; Kütükcxüler N.; Atilla G.; Gingival crevicular fluid levels of cathelicidin ll-37 and interleukin-18 in patients with chronic periodontitis. Journal of Periodontology 2009 80 6 969 976 10.1902/jop.2009.080532 2-s2.0-67649964706
68. Panyutich A.; Shi J.; Boutz P. L.; Zhao C.; Ganz T.; Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infection and Immunity 1997 65 3 978 985 2-s2.0-0031028188
69. Sorensen O. E.; Follin P.; Johnsen A. H.; Calafat J.; Sandra Tjabringa G.; Hiemstra P. S.; Borregaard N.; Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001 97 12 3951 3959 10.1182/blood.V97.12.3951 2-s2.0-0035877995
70. Nizet V.; Gallo R. L.; Cathelicidins and innate defense against invasive bacterial infection. Scandinavian Journal of Infectious Diseases 2003 35 9 670 676 10.1080/00365540310015629 2-s2.0-0242351607
71. Bachrach G.; Chaushu G.; Zigmond M.; Yefenof E.; Stabholz A.; Shapira J.; Merrick J.; Chaushu S.; Salivary LL-37 secretion in individuals with down syndrome is normal. Journal of Dental Research 2006 85 10 933 936 10.1177/154405910608501012 2-s2.0-33750067402
72. Gutner M.; Chaushu S.; Balter D.; Bachrach G.; Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis. Infection and Immunity 2009 77 12 5558 5563 10.1128/IAI.00648-09 2-s2.0-72449155528
73. Inomata M.; Into T.; Murakami Y.; Suppressive effect of the antimicrobial peptide LL-37 on expression of IL-6, IL-8 and CXCL10 induced by Porphyromonas gingivalis cells and extracts in human gingival fibroblasts. European Journal of Oral Sciences 2010 118 6 574 581 10.1111/j.1600-0722.2010.00775.x 2-s2.0-78649605533
74. Pütsep K.; Carlsson G.; Boman H. G.; Andersson M.; Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. The Lancet 2002 360 9340 1144 1149 10.1016/S0140-6736(02)11201-3 2-s2.0-0037068959
75. Oren Z.; Shai Y.; Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry 1997 36 7 1826 1835 10.1021/bi962507l 2-s2.0-0031024551
76. Chertov O.; Michiel D. F.; Xu L.; Wang J. M.; Tani K.; Murphy W. J.; Longo D. L.; Taub D. D.; Oppenheim J. J.; Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. Journal of Biological Chemistry 1996 271 6 2935 2940 10.1074/jbc.271.6.2935 2-s2.0-0030038197
77. Yang D.; Oppenheim J. J.; Alarmins and antimicrobial immunity. Medical Mycology 2009 47 S146 S153 10.1080/13693780902721416 2-s2.0-67651101168
78. Pröpper C.; Huang X.; Roth J.; Sorg C.; Nacken W.; Analysis of the MRP8-MRP14 protein-protein interaction by the two- hybrid system suggests a prominent role of the C-terminal domain of S100 proteins in dimer formation. Journal of Biological Chemistry 1999 274 1 183 188 10.1074/jbc.274.1.183 2-s2.0-0039328006
79. Dorin J. R.; Novak M.; Hill R. E.; Brock D. J.; Secher D. S.; van Heyningen V.; A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature 1987 326 6113 614 617 10.1038/326614a0 2-s2.0-0023648813
80. Dale I.; Brandtzaeg P.; Fagerhol M. K.; Scott H.; Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. The American Journal of Clinical Pathology 1985 84 1 24 34 2-s2.0-0021927616
81. Odink K.; Cerletti N.; Bruggen J.; Clerc R. G.; Tarcsay L.; Zwadlo G.; Gerhards G.; Schlegel R.; Sorg C.; Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987 330 6143 80 82 10.1038/330080a0 2-s2.0-0023200684
82. Brandtzaeg P.; Dale I.; Fagerhol M. K.; Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. The American Journal of Clinical Pathology 1987 87 6 700 707 2-s2.0-0023227486
83. Sander J.; Fagerhol M. K.; Bakken J. S.; Dale I.; Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. Scandinavian Journal of Clinical & Laboratory Investigation 1984 44 4 357 362 10.3109/00365518409083820 2-s2.0-0021275970
84. Cuida M.; Halse A.-K.; Johannessen A. C.; Tynning T.; Jonsson R.; Indicators of salivary gland inflammation in primary Sjögren's syndrome. European Journal of Oral Sciences 1997 105 3 228 233 10.1111/j.1600-0722.1997.tb00205.x 2-s2.0-0031158893
85. Hammer H. B.; Kvien T. K.; Glennas A.; Melby K.; A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clinical and Experimental Rheumatology 1995 13 1 59 64 2-s2.0-0028958907
86. Marionnet C.; Bernerd F.; Dumas A.; Verrecchia F.; Mollier K.; Compan D.; Bernard B.; Lahfa M.; Leclaire J.; Medaisko C.; Mehul B.; Seité S.; Mauviel A.; Dubertret L.; Modulation of gene expression induced in human epidermis by environmental stress in vivo. Journal of Investigative Dermatology 2003 121 6 1447 1458 10.1111/j.1523-1747.2003.12629.x 2-s2.0-10744230354
87. Gregory S. G.; Barlow K. F.; McLay K. E.; Kaul R.; Swarbreck D.; Dunham A.; Scott C. E.; Howe K. L.; The DNA sequence and biological annotation of human chromosome 1. Nature 2006 441 315 321
88. Kerkhoff C.; Klempt M.; Sorg C.; Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochimica et Biophysica Acta-Molecular Cell Research 1998 1448 2 200 211 10.1016/S0167-4889(98)00144-X 2-s2.0-0032435515
89. Benet Bosco Dhas D.; Vishnu Bhat B.; Bahubali Gane D.; Role of calprotectin in infection and inflammation. Current Pediatric Research 2012 16 2 83 94 2-s2.0-84869075548
90. Kido J.-I.; Nakamura T.; Kido R.; Ohishi K.; Yamauchi N.; Kataoka M.; Nagata T.; Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease. Journal of Clinical Periodontology 1999 26 10 653 657 10.1034/j.1600-051X.1999.261004.x 2-s2.0-0033210931
91. Nakamura T.; Kido J.-I.; Kido R.; Ohishi K.; Yamauchi N.; Kataoka M.; Nagata T.; The association of calprotectin level in gingival crevicular fluid with gingival index and the activities of collagenase and aspartate aminotransferase in adult periodontitis patients. Journal of Periodontology 2000 71 3 361 367 10.1902/jop.2000.71.3.361 2-s2.0-0034150307
92. Gómez R. S.; Langer P.; Pelka M.; von den Driesch P.; Johannessen A. C.; Simon M. Jr.; Variational expression of functionally different macrophage markers (27E10, 25F9, RM3/1) in normal gingiva and inflammatory periodontal disease. Journal of Clinical Periodontology 1995 22 5 341 346 10.1111/j.1600-051X.1995.tb00159.x 2-s2.0-0029299066
93. Hessian P. A.; Edgeworth J.; Hogg N.; MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. Journal of Leukocyte Biology 1993 53 2 197 204 2-s2.0-0027547066
94. Heizmann C. W.; Fritz G.; Schäfer B. W.; S100 proteins: structure, functions and pathology. Frontiers in Bioscience 2002 7 d1356 d1368 10.2741/heizmann 2-s2.0-0036580943
95. Cuida M.; Brun J. G.; Tynning T.; Jonsson R.; Calprotectin levels in oral fluids: the importance of collection site. European Journal of Oral Sciences 1995 103 1 8 10 10.1111/j.1600-0722.1995.tb00003.x 2-s2.0-0029242471
96. Steinbakk M.; Naess-Andresen C.-F.; Lingaas E.; Dale I.; Brandtzaeg P.; Fagerhol M. K.; Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. The Lancet 1990 336 8718 763 765 10.1016/0140-6736(90)93237-J 2-s2.0-0025143194
97. Nisapakultorn K.; Ross K. F.; Herzberg M. C.; Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infection and Immunity 2001 69 7 4242 4247 10.1128/IAI.69.7.4242-4247.2001 2-s2.0-0034978030
98. Murthy A. R. K.; Lehrer R. I.; Harwig S. S. L.; Miyasaki K. T.; In vitro candidastatic properties of the human neutrophil calprotectin complex. Journal of Immunology 1993 151 11 6291 6301 2-s2.0-0027432312
99. Eversole L. R.; Miyasaki K. T.; Christensen R. E.; Keratinocyte expression of calprotectin in oral inflammatory mucosal diseases. Journal of Oral Pathology and Medicine 1993 22 7 303 307 10.1111/j.1600-0714.1993.tb01077.x 2-s2.0-0027180324
100. Damo S. M.; Kehl-Fie T. E.; Sugitani N.; Holt M. E.; Rathi S.; Murphy W. J.; Zhang Y.; Betz C.; Hench L.; Fritz G.; Skaar E. P.; Chazin W. J.; Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens. Proceedings of the National Academy of Sciences of the United States of America 2013 110 10 3841 3846 10.1073/pnas.1220341110 2-s2.0-84874640244
101. Brandtzaeg P.; Gabrielsen T.-O.; Dale I.; Muller F.; Steinbakk M.; Fagerhol M. K.; The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Advances in Experimental Medicine and Biology 1995 371 201 206 10.1007/978-1-4615-1941-6-41 2-s2.0-0029100017
102. Zimmer D. B.; Eubanks J. O.; Ramakrishnan D.; Criscitiello M. F.; Evolution of the S100 family of calcium sensor proteins. Cell Calcium 2013 53 3 170 179 10.1016/j.ceca.2012.11.006 2-s2.0-84875237103
103. Kerkhoff C.; Voss A.; Scholzen T. E.; Averill M. M.; Zänker K. S.; Bornfeldt K. E.; Novel insights into the role of S100A8/A9 in skin biology. Experimental Dermatology 2012 21 11 822 826 10.1111/j.1600-0625.2012.01571.x 2-s2.0-84871919150
104. Nacken W.; Roth J.; Sorg C.; Kerkhoff C.; S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microscopy Research and Technique 2003 60 6 569 580 10.1002/jemt.10299 2-s2.0-0242335600
105. González-López A.; Aguirre A.; López-Alonso I.; Amado L.; Astudillo A.; Fernández-García M. S.; Suárez M. F.; Batalla-Solís E.; Colado E.; Albaiceta G. M.; MMP-8 deficiency increases TLR/RAGE ligands S100A8 and S100A9 and exacerbates lung inflammation during endotoxemia. PLoS ONE 2012 7 6 e39940 10.1371/journal.pone.0039940 2-s2.0-84863090301
106. Kitamura K.; Kangawa K.; Kawamoto M.; Ichiki Y.; Nakamura S.; Matsuo H.; Eto T.; Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochemical and Biophysical Research Communications 1993 192 2 553 560 10.1006/bbrc.1993.1451 2-s2.0-0027197671
107. Cheung B.; Leung R.; Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clinical Science 1997 92 1 59 62 2-s2.0-0031023840
108. Hata T.; Miyazaki K.; Matsui K.; Decreased circulating adrenomedullin in preeclampsia. The Lancet 1997 350 9091 1600 10.1016/S0140-6736(05)64016-0 2-s2.0-0031556864
109. Kitamura K.; Sakata J.; Kangawa K.; Kojima M.; Matsuo H.; Eto T.; Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochemical and Biophysical Research Communications 1993 194 2 720 725 10.1006/bbrc.1993.1881 2-s2.0-0027181496
110. Allaker R. P.; Zihni C.; Kapas S.; An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. FEMS Immunology and Medical Microbiology 1999 23 4 289 293 10.1016/S0928-8244(98)00148-5 2-s2.0-0032934134
111. Ishimitsu T.; Kojima M.; Kangawa K.; Hino J.; Matsuoka H.; Kitamura K.; Eto T.; Matsuo H.; Genomic structure of human adrenomedullin gene. Biochemical and Biophysical Research Communications 1994 203 1 631 639 10.1006/bbrc.1994.2229 2-s2.0-0028092742
112. Gumusel B.; Chang J.-K.; Hyman A.; Lippton H.; Adrenotensin: an ADM gene product with the opposite effects of ADM. Life Sciences 1995 57 8 PL87 PL90 10.1016/0024-3205(95)02012-8 2-s2.0-0029129271
113. Kapas S.; Bansal A.; Bhargava V.; Maher R.; Malli D.; Hagi-Pavli E.; Allaker R. P.; Adrenomedullin expression in pathogen-challenged oral epithelial cells. Peptides 2001 22 9 1485 1489 10.1016/S0196-9781(01)00470-3 2-s2.0-0034888528
114. Kapas S.; Luisa Tenchini M.; Farthing P. M.; Regulation of adrenomedullin secretion in cultured human skin and oral keratinocytes. Journal of Investigative Dermatology 2001 117 2 353 359 10.1046/j.0022-202X.2001.01426.x 2-s2.0-0035720493
115. Kapas S.; Pahal K.; Cruchley A. T.; Hagi-Pavli E.; Hinson J. P.; Expression of adrenomedullin and its receptors in human salivary tissue. Journal of Dental Research 2004 83 4 333 337 10.1177/154405910408300412 2-s2.0-2342506575
116. Allaker R. P.; Grosvenor P. W.; McAnerney D. C.; Sheehan B. E.; Srikanta B. H.; Pell K.; Kapas S.; Mechanisms of adrenomedullin antimicrobial action. Peptides 2006 27 4 661 666 10.1016/j.peptides.2005.09.003 2-s2.0-33645395054
117. He H.; Bessho H.; Fujisawa Y.; Horiuchi K.; Tomohiro A.; Kita T.; Aki Y.; Kimura S.; Tamaki T.; Abe Y.; Effects of a synthetic rat adrenomedullin on regional hemodynamics in rats. European Journal of Pharmacology 1995 273 3 209 214 10.1016/0014-2999(94)00683-X 2-s2.0-0028891290
118. Friedman A.; Todd L.; Baker R. S.; Clark K. E.; Uterine vascular effects of adrenomedullin. Journal of the Society for Gynecologic Investigation 1998 5 F449
119. Samson W. K.; Murphy T.; Schell D. A.; A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology 1995 136 5 2349 2352 2-s2.0-0028921785
120. Nussdorfer G. G.; Paracrine control of adrenal cortical function by medullary chromaffin cells. Pharmacological Reviews 1996 48 4 495 530 2-s2.0-0030456935
121. Martínez A.; Weaver C.; López J.; Bhathena S. J.; Elsasser T. H.; Miller M.-J.; Moody T. W.; Unsworth E. J.; Cuttitta F.; Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology 1996 137 6 2626 2632 10.1210/en.137.6.2626 2-s2.0-0029935931
122. Cebra J. J.; Influences of microbiota on intestinal immune system development. The American Journal of Clinical Nutrition 1999 69 5 1046S 1051S 2-s2.0-0032935617
123. Hooper L. V.; Wong M. H.; Thelin A.; Hansson L.; Falk P. G.; Gordon J. I.; Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001 291 5505 881 884 10.1126/science.291.5505.881 2-s2.0-0035793372
124. Mazmanian S. K.; Cui H. L.; Tzianabos A. O.; Kasper D. L.; An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005 122 1 107 118 10.1016/j.cell.2005.05.007 2-s2.0-22144490199
125. Reid G.; Jass J.; Sebulsky M. T.; McCormick J. K.; Potential uses of probiotics in clinical practice. Clinical Microbiology Reviews 2003 16 4 658 672 10.1128/CMR.16.4.658-672.2003 2-s2.0-0142095003
126. Chung W. O.; Dale B. A.; Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infection and Immunity 2004 72 1 352 358 10.1128/IAI.72.1.352-358.2004 2-s2.0-0346881404
127. Hasegawa Y.; Mans J. J.; Mao S.; Lopez M. C.; Baker H. V.; Handfield M.; Lamont R. J.; Gingival epithelial cell transcriptional responses to commensal and opportunistic oral microbial species. Infection and Immunity 2007 75 5 2540 2547 10.1128/IAI.01957-06 2-s2.0-34248334199
128. Neish A. S.; Gewirtz A. T.; Zeng H.; Young A. N.; Hobert M. E.; Karmali V.; Rao A. S.; Madara J. L.; Prokaryotic regulation of epithelial responses by inhibition of I B-α ubiquitination. Science 2000 289 5484 1560 1563 10.1126/science.289.5484.1560 2-s2.0-0034284803
129. Rakoff-Nahoum S.; Paglino J.; Eslami-Varzaneh F.; Edberg S.; Medzhitov R.; Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004 118 2 229 241 10.1016/j.cell.2004.07.002 2-s2.0-3242664636
130. Tien M.-T.; Girardin S. E.; Regnault B.; Le Bourhis L.; Dillies M.-A.; Coppée J.-Y.; Bourdet-Sicard R.; Sansonetti P. J.; Pédron T.; Antiinflammatory effect of Lactobacillus casei on Shigella -infected human intestinal epithelial cells. Journal of Immunology 2006 176 6 1228 1237 2-s2.0-33644836521
131. Grangette C.; Nutten S.; Palumbo E.; Morath S.; Hermann C.; Dewulf J.; Pot B.; Hartung T.; Hols P.; Mercenier A.; Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proceedings of the National Academy of Sciences of the United States of America 2005 102 29 10321 10326 10.1073/pnas.0504084102 2-s2.0-22544476790
132. Cosseau C.; Devine D. A.; Dullaghan E.; Gardy J. L.; Chikatamarla A.; Gellatly S.; Yu L. L.; Pistolic J.; Falsafi R.; Tagg J.; Hancock R. E. W.; The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infection and Immunity 2008 76 9 4163 4175 10.1128/IAI.00188-08 2-s2.0-51949091201
133. Giles F. J.; Miller C. B.; Hurd D. D.; A phase III, randomized, double-blind, placebo-controlled, multinational trial of Iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT Trial). Leukemia & Lymphoma 2003 44 7 1165 1172 10.1080/1042819031000079159 2-s2.0-0037986557
134. Elad S.; Epstein J. B.; Raber-Durlacher J.; Donnelly P.; Strahilevitz J.; The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial. Journal of Oral Pathology & Medicine 2012 41 3 229 234 10.1111/j.1600-0714.2011.01094.x 2-s2.0-84857783762